title: Prevalence of anti-HCV among haemodialysis patients in Turkey: a multicentre study.
authors.affiliation: Ondokuz Mayis University School of Medicine, Samsun, Turkey.
authors.forename: T
authors.initials: T
authors.lastname: Akpolat
authors.forename: N
authors.initials: N
authors.lastname: Arik
authors.forename: M
authors.initials: M
authors.lastname: Günaydin
authors.forename: C
authors.initials: C
authors.lastname: Utaş
authors.forename: K
authors.initials: K
authors.lastname: Dilek
authors.forename: S
authors.initials: S
authors.lastname: Caglar
authors.forename: F
authors.initials: F
authors.lastname: Candan
authors.forename: G
authors.initials: G
authors.lastname: Süleymanlar
authors.forename: S
authors.initials: S
authors.lastname: Paydaş
authors.forename: S
authors.initials: S
authors.lastname: Sen
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D002648:Child; D004797:Enzyme-Linked Immunosorbent Assay; D005260:Female; D016174:Hepacivirus / Q000302:isolation & purification; D006508:Hepatitis Antibodies / Q000097:blood*; D006526:Hepatitis C / Q000453:epidemiology* / Q000517:prevention & control; D018937:Hepatitis C Antibodies; D006801:Humans; D007676:Kidney Failure, Chronic / Q000628:therapy; D008297:Male; D008875:Middle Aged; D015995:Prevalence; D006435:Renal Dialysis / Q000009:adverse effects*; D012189:Retrospective Studies; D012307:Risk Factors; D014421:Turkey / Q000453:epidemiology
chemical_list: D006508:Hepatitis Antibodies; D018937:Hepatitis C Antibodies